MedPacto, Inc. (KOSDAQ:235980)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,170.00
+40.00 (0.78%)
Apr 10, 2026, 3:30 PM KST
Market Cap177.20B +41.1%
Revenue (ttm)3.90B
Net Income-12.81B
EPS-374.00
Shares Out34.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume105,464
Average Volume647,943
Open5,250.00
Previous Close5,130.00
Day's Range5,080.00 - 5,250.00
52-Week Range2,750.00 - 8,650.00
Beta0.40
RSI43.48
Earnings DateApr 3, 2026

About MedPacto

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 235980
Full Company Profile

Financial Performance

Financial Statements